Pictures from the Annual CHFR Symposium 2019

The 17th Annual CHFR Symposium on Heart Research was arranged by Center for Heart Failure Research between September 18 and September 20, 2019. The Annual Symposium is an important opportunity for Norwegian scientists to meet with international scientists at the forefront of their field in an informal atmosphere. Below are some pictures from this year’s Symposium, as well as some brief information on the speakers and topics.

Moderated poster sessions was hosted by NORHEART. Pictures and more information about the poster sessions are provided here.

THURSDAY SEPTEMBER 19


OPENING SESSION

SVEIN STØLEN, Rector, University of Oslo:
Opening remarks

JOHN JARCHO, Harvard Medical School, USA:
Key note lecture: The state of the art in heart failure


NEW DEVELOPMENTS IN CARDIAC IMAGING AND HEART FAILURE TREATMENT

ROBERT D. GROPLER, Washington University School of Medicine, USA:
Cardiovascular molecular imaging: Challenges and opportunities

JARDEEP JHUND, University of Glasgow, United Kingdom:
Breaking news: Lessons and questions from PARAGON-HF and DAPA-HF


PERSONALIZED APPROACHES TO ATRIAL FIBRILLATION

INGRID CHRISTOPHERSEN, Bærum Hospital and Norwegian Atrial Fibrillation Research Network, Norway:
What is the role of genetics in atrial fibrillation? Status in 2019

JOSE JALIFE, University of Michigan, USA:
Translational studies toward personalized stratification of patients progressing from paroxysmal to persistent atrial fibrillation


FRIDAY SEPTEMBER 20


NEW INTERVENTIONS FOR TREATMENT AND PREVENTION OF CARDIAC DISEASE

PAUL D. THOMPSEON, University of Connecticut, USA:
What cardiologists should  know about exercise

GUY READER, May Clinic and Foundation, USA:
Transcatheter intracardiac shunt device for heart failure with preserved ejection fraction


MECHANISMS AND CONSEQUENCES OF INFLAMMATION

BURNS BLAXALL, University of Cincinnati Colege of Medicine, USA:
New targets for cardiac and renal fibrosis

DOBROMIR DOBREV, University of Duisburg-Essen, Germany:
Role of NLPR3 inflammatory signaling in atrial fibrillation


RISK FACTORS AND CAUSES OF HEART FAILURE

LINA BADIMON, Hospital de la Santa Creu i Sant Pau, Spain:
Coronary artery disease, ischemia and myocardial damage: The continuum to heart failure?

PETER GANZ, University of California, USA:
Proteomics to improve risk prediction for cardiovascular and other diseases and making drug development safer patients

 


FUTURE OF CARDIAC RESEARCH

ØYVIND HAUGEN LIE, Oslo University Hospital, Norway:
Cardiac arrest in sports: Knowledge and misconception

(All photos: Anders Revdal, NORHEART)